Hypertension induced by St. John's wort: A case report

Pharmacopsychiatry

Volumn 36, Issue 1, 2003, Pages 32-

  Zullino, Daniele ^a   Borgeat, F ^a  

^a DEPT UNIV DE PSYCHIATRIE ADULTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; HYPERICUM PERFORATUM EXTRACT; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CASE REPORT; DRUG EFFECT; DRUG MECHANISM; DRUG USE; HUMAN; HYPERICUM PERFORATUM; HYPERTENSION; MALE; NORADRENALIN UPTAKE; PRIORITY JOURNAL; SELF MEDICATION;

HUMANS; HYPERICUM; HYPERTENSION; MALE; MIDDLE AGED; PLANT PREPARATIONS; STRESS, PSYCHOLOGICAL;

EID: 0345505655     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-38086     Document Type: Article

References (4)

1. 2 extract on dopamine and serotonin release in the rat central nervous system. Pharmacopsychiat 2000; 33: 14-18
2. Grohmann R, Rüther E, Engel RR, Hippius H. Assessment of adverse drug reactions in psychiatric in patients with the AMSP drug safety program: methods and first results for tricyclic antidepressants and SSRI. Pharmacopsychiat 1999; 32: 21-28
3. Müller WE, Singer A, Wonnemann M, Hafner U, Rolli M, Schäfer C. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Pharmacopsychiat 1998; 31: 16-21
4. Thase ME. Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients. J Clin Psychiatry 1998; 59: 502-508